Research Reference Guide

TB-500 in the Recovery Research Literature

Research-focused overview of TB-500 (thymosin beta-4 fragment) in the workout recovery literature: what it is, preclinical findings, regulatory status, and safety considerations. Educational only.

7 min readUpdated 2026-04-08Reviewed by Dr. Emily Tran, DPT

In short

TB-500 is a synthetic peptide fragment based on the naturally occurring protein thymosin beta-4. It is investigational — the peer-reviewed base is primarily preclinical, it is not FDA-approved for human use, and WADA has historically listed thymosin beta-4 derivatives in prohibited categories for competitive athletes.

Key points

  • TB-500 is a synthetic peptide fragment referenced in tissue-repair research signaling studies.
  • It is not FDA-approved and is not sold on this site for human consumption.
  • The peer-reviewed literature is predominantly preclinical, not human clinical trial data.
  • Thymosin beta-4 derivatives have appeared on WADA-prohibited categories — verify current list before competition.
  • Purity and sourcing are the most commonly cited safety variables.

What is TB-500?

TB-500 is a research peptide based on a fragment of thymosin beta-4, a naturally occurring protein found in nearly all human cells. Researchers have studied thymosin beta-4 in preclinical models for actin regulation and cellular migration signaling — the studied processes that underlie tissue-repair research.

What has the research literature examined?

Published research on TB-500 and thymosin beta-4 fragments includes preclinical work in cardiac tissue, corneal tissue, and dermal wound models. Reviewers consistently note that translation to controlled human clinical trials is limited. Secondary sources marketing dramatic human outcomes should be cross-checked against primary PubMed literature.

How is TB-500 discussed in athletic communities?

Athletic community references to TB-500 typically involve informal discussion of soft-tissue recovery signaling. These references are anecdotal, not clinical evidence, and are not equivalent to a use recommendation or endorsement of any protocol.

Regulatory and WADA status

TB-500 (thymosin beta-4 fragments) has been referenced in WADA prohibited categories in past cycles. Any competitive athlete considering education about this compound must independently verify the current WADA Prohibited List. TB-500 is not FDA-approved for human use.

Safety considerations documented in the literature

Key safety variables include: purity of unregulated research-chemical supply, absence of long-term human safety data, potential for interaction with other pharmacological agents, and jurisdictional legal risk. None of these variables can be assessed without professional medical and legal counsel.

TB-500 at a Glance

AspectSummary
Regulatory statusResearch chemical — not FDA-approved
Primary study basePreclinical models (cardiac, dermal, ocular)
Human trial dataLimited
WADA statusHistorically prohibited categories — verify current list
Main documented risk areaPurity, unknown long-term effects, legal status

Frequently asked questions

Is TB-500 the same as thymosin beta-4?

TB-500 is a synthetic peptide fragment derived from the thymosin beta-4 sequence — they are related but not identical, and this distinction matters when reading primary research.

Is TB-500 legal for athletes to use in competition?

Thymosin beta-4 derivatives have been referenced on WADA prohibited categories. Always check the current WADA Prohibited List before competition.

Are there human clinical trials on TB-500?

Peer-reviewed human trial data on TB-500 specifically is limited. Most published work is preclinical.

Related product pages

Related guides

Medical & Legal Disclaimer

This page is educational reference material only and does not constitute medical, legal, or professional advice. Peptides discussed may be unapproved, restricted, or prohibited in your jurisdiction and in competitive athletic contexts. Products referenced on this site are not intended to diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before considering any research compound. See our Editorial Policy and Disclaimer for full context.